Molnupiravir in the treatment of patients with influenza or acute respiratory viral infections: a multicenter comparative randomized double-blind placebo-controlled trial

The aim. To evaluate the efficacy and safety of molnupiravir compared to placebo in patients with influenza and/or ARVI.Materials and methods. The study involved 300 patients. The study included patients aged 18 to 80 years with clinical signs of influenza/ARVI (duration no more than 48 hours): elev...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	O. M. Drapkina, A. Yu. Gorshkov, T I. Chudinovskikh, E. N. Simakina, G. V. Rodoman, V. V. Popova, I. V. Balaban, L. A. Balykova, N. M. Selezneva, N. V. Kirichenko, R. S. Kozlov, D. A. Bystritskii, V. B. Vasilyuk, K. Ya. Zaslavskaya, P. A. Bely, K. N. Koryanova, E. S. Mishchenko, A. V. Taganov, L. A. Pochaevets, V. S. Scherbakova
स्वरूप:	Artigo
भाषा:	Russo
प्रकाशित:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2025-09-01
श्रृंखला:	Фармация и фармакология (Пятигорск)
विषय:	молнупиравир грипп острая респираторная вирусная инфекция орви клиническое исследование инфекционные болезни пульмонология эсперавир®
ऑनलाइन पहुंच:	https://www.pharmpharm.ru/jour/article/view/1715
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!